H

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566

Watchlist Manager
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Watchlist
Price: 29.6 CNY -0.57%
Market Cap: 27.1B CNY
Have any thoughts about
Hubei Jumpcan Pharmaceutical Co Ltd?
Write Note
Hubei Jumpcan Pharmaceutical Co Ltd
/
Balance Sheet
/
Deferred Income Tax

Hubei Jumpcan Pharmaceutical Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hubei Jumpcan Pharmaceutical Co Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
H
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Deferred Income Tax
¥123.3m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Deferred Income Tax
¥255m
CAGR 3-Years
28%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Deferred Income Tax
¥22.5m
CAGR 3-Years
-23%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Deferred Income Tax
¥85.1m
CAGR 3-Years
65%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Deferred Income Tax
¥91.3m
CAGR 3-Years
18%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hubei Jumpcan Pharmaceutical Co Ltd
Glance View

Market Cap
27.3B CNY
Industry
Pharmaceuticals

In the bustling landscape of China's pharmaceutical industry, Hubei Jumpcan Pharmaceutical Co Ltd stands as a key player, weaving together tradition and modernity. Founded in 1951, this company has curated a journey of evolution—from its roots in the rich tapestry of traditional Chinese medicine to its current standing as a significant contributor to the healthcare sector. Core to Jumpcan's operation is its production and distribution of a diverse array of pharmaceutical products that span across various therapeutic areas, including digestive health, dermatology, and respiratory care. With an adept focus on over-the-counter medications and prescription drugs, Jumpcan effectively meets the health needs of a broad demographic, leveraging both the enduring appeal of traditional remedies and the growing demand for contemporary medical solutions. The business prowess of Jumpcan is deeply entwined with its strategy of innovation and adherence to quality standards, ensuring its pharmaceutical offerings are not only effective but also safe for consumption. Anchored in robust R&D initiatives, the company continues to enhance its product line, incorporating advanced technology and scientific research to produce medicines that align with global quality benchmarks. Furthermore, Jumpcan thrives on an extensive distribution network that spans across China, ensuring widespread accessibility of its products. By maintaining a keen understanding of the market dynamics and consumer preferences, Jumpcan artfully aligns its operations to capitalize on both domestic and international opportunities, thus solidifying its financial standing and perpetuating its growth within the dynamic corridors of the pharmaceutical industry.

Intrinsic Value
47.66 CNY
Undervaluation 38%
Intrinsic Value
Price
H
What is Intrinsic Value?

See Also

What is Hubei Jumpcan Pharmaceutical Co Ltd's Deferred Income Tax?
Deferred Income Tax
123.3m CNY

Based on the financial report for Sep 30, 2024, Hubei Jumpcan Pharmaceutical Co Ltd's Deferred Income Tax amounts to 123.3m CNY.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
6%

Over the last year, the Deferred Income Tax growth was -10%. The average annual Deferred Income Tax growth rates for Hubei Jumpcan Pharmaceutical Co Ltd have been 5% over the past three years , 6% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.